Sign in

    David White

    Managing Director and Senior Analyst at David White Financials

    David White is a Managing Director and Senior Analyst at David White Financials, specializing in equity research with a focus on consumer goods, financial services, and technology sectors. He provides in-depth coverage of companies including Procter & Gamble, JPMorgan Chase, and Apple, with a consistent track record demonstrated by a 68% success rate and an average annualized return of 14% on his recommendations according to industry platforms. White began his career in equity research at Morgan Stanley in 2007 and transitioned through various boutique firms before founding David White Financials in 2019. He is a FINRA-registered representative holding Series 7 and Series 63 licenses and has received recognition among the top 100 analysts on TipRanks for value-focused investment strategies.

    David White's questions to GALECTIN THERAPEUTICS (GALT) leadership

    David White's questions to GALECTIN THERAPEUTICS (GALT) leadership • Q4 2015

    Question

    David White asked for the reasoning behind the removal of Jim Czirr as Chairman and whether CEO Peter Traber had orchestrated the change and assumed his business duties.

    Answer

    Peter Traber (President, CEO & CMO) clarified that he did not orchestrate the change, stating it was a decision made by the Board of Directors. He explained the board felt it was appropriate to transition leadership to Dr. Marc Rubin, the former Lead Director, to align with the company's shift toward advanced clinical development. Traber affirmed that Jim Czirr remains an important and active member of the board.

    Ask Fintool Equity Research AI